Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
Department of Intensive Care, St Vincent's Hospital, Sydney, NSW, Australia.
Crit Care Resusc. 2020 Mar;22(1):26-34. doi: 10.51893/2020.1.oa3.
Patients with prolonged cardiac arrest that is not responsive to conventional cardiopulmonary resuscitation have poor outcomes. The use of extracorporeal membrane oxygenation (ECMO) in refractory cardiac arrest has shown promising results in carefully selected cases. We sought to validate the results from an earlier extracorporeal cardiopulmonary resuscitation (ECPR) study (the CHEER trial).
Prospective, consecutive patients with refractory in-hospital (IHCA) or out-of-hospital cardiac arrest (OHCA) who met predefined inclusion criteria received protocolised care, including mechanical cardiopulmonary resuscitation, initiation of ECMO, and early coronary angiography (if an acute coronary syndrome was suspected).
Twenty-five patients were enrolled in the study (11 OHCA, 14 IHCA); the median age was 57 years (interquartile range [IQR], 39-65 years), and 17 patients (68%) were male. ECMO was established in all patients, with a median time from arrest to ECMO support of 57 minutes (IQR, 38-73 min). Percutaneous coronary intervention was performed on 18 patients (72%). The median duration of ECMO support was 52 hours (IQR, 24-108 h). Survival to hospital discharge with favourable neurological recovery occurred in 11/25 patients (44%, of which 72% had IHCA and 27% had OHCA). When adjusting for lactate, arrest to ECMO flow time was predictive of survival (odds ratio, 0.904; = 0.035).
ECMO for refractory cardiac arrest shows promising survival rates if protocolised care is applied in conjunction with predefined selection criteria.
对常规心肺复苏无反应的长时间心脏骤停患者预后不良。在精心挑选的病例中,体外膜肺氧合(ECMO)在难治性心脏骤停中的应用显示出有希望的结果。我们旨在验证早期体外心肺复苏(ECPR)研究(CHEER 试验)的结果。
符合预设纳入标准的难治性院内(IHCA)或院外心脏骤停(OHCA)的前瞻性连续患者接受了方案化治疗,包括机械心肺复苏、启动 ECMO 和早期冠状动脉造影(如果怀疑急性冠状动脉综合征)。
该研究纳入了 25 名患者(11 例 OHCA,14 例 IHCA);中位年龄为 57 岁(四分位距 [IQR],39-65 岁),17 名患者(68%)为男性。所有患者均建立了 ECMO,从心脏骤停到 ECMO 支持的中位时间为 57 分钟(IQR,38-73 分钟)。对 18 名患者(72%)进行了经皮冠状动脉介入治疗。ECMO 支持的中位持续时间为 52 小时(IQR,24-108 小时)。25 名患者中有 11 名(44%)存活至出院且神经功能恢复良好,其中 72%为 IHCA,27%为 OHCA。在校正乳酸后,从心脏骤停到 ECMO 血流时间是预测生存的因素(比值比,0.904; = 0.035)。
如果结合预设的选择标准应用方案化治疗,ECMO 治疗难治性心脏骤停的存活率有希望提高。